20.1 C
New York

Tag: Institutional

Bitcoin Options Expire

The bitcoin and ethereum options on Deribit, one of the largest crypto derivatives exchange, expired earlier today. This month saw the largest open interest in...

Top News

Grayscale slams the gavel; AVAX & DOT join the family, SNX & SUSHI cast out

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass AdoptionThough crypto is said to be decentralized, Grayscale’s recognition of crypto assets certainly help define the trajectories of coin or token prices. However, more than just new product additions, asset removals are also key in understanding what institutional investors want – or don’t want. No gray area here In a press release, Grayscale Investments shared […]

ADDX Launches Private Market Services For Wealth Managers; StashAway, CGS-CIMB Among The First On Board

Wealth managers can offer clients fractional access to a full suite of private market assets, helping them gain a competitive advantage over platforms with...

Legend Capital’s Portfolio Company Recbio Lists on HKEX Successfully

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

HONG KONG, Apr 7, 2022 - (ACN Newswire) - On 31 March 2022, Legend Capital's portfolio company Jiangsu Recbio Technology Co., Ltd. ("Recbio", stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange. The listing makes Recbio "the first HPV vaccine stock in Hong Kong" and "the first novel adjuvant vaccine stock in Hong Kong". Recbio is expected to inject new vitality into the capital market in Hong Kong.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Recbio is a novel vaccine company driven by independent novel adjuvant technology. It has built a comprehensive and high-valued vaccine portfolio consisting of 12 candidates, covering cervical cancer, COVID-19, adult tuberculosis, shingles, HFMD, influenza, etc. Recbio is primarily focused on the R&D of HPV vaccine candidates. Its core product REC603, a recombinant HPV 9-valent vaccine, is currently under phase III clinical trial, and is expected to become the first approved domestic HPV 9-valent vaccine in China. In addition, Recbio has also begun to deploy in the mRNA vaccine field and is currently developing the COVID-19 mRNA vaccine.

Recbio has constructed the three core technology platforms consisting of independent novel adjuvants, protein engineering and immunological evaluation. It is one of the few companies capable of independent development of novel adjuvants and the novel adjuvants it developed have been successfully applied in various innovative vaccines such as COVID-19 vaccines, HPV vaccines and shingles vaccines.

Legend Capital led Recbio's Series B financing in 2020, through a coordinated investment of the comprehensive growth fund and the healthcare fund and re-upped on its Series C financing in 2021, marking Recbio another successful case towards Legend Capital's multi-fund coordinated investment. As the major institutional investor to Recbio, Legend Capital provides Recbio with multi-faceted support involving corporate governance, business strategy, technical route, R&D resources, management improvement and financial support.

Dr. Liu Yong, the Founder, Chairman of the Board, and General Manager of Recbi, said, "We are much appreciated Legend Capital's long-term and firm support to Recbio. As the institutional investor with the largest shareholding in the company, Legend Capital's investment philosophy of 'Business First, People Crucial' is highly compatible with our corporate culture. Legend Capital has always supported our management team in major decision-making and continued to assist in the development, becoming one of the most trusted and respected investors of Recbio. The listing is just a new chapter of Recbio, and the management team hopes to work closely with all the investors represented by Legend Capital to write a new legend!"

Hank Zhou, the Co-Chief Investment Officer of Legend Capital, said: "Congratulations to Recbio and its team led by founder Dr. Liu Yong. Liu has been engaged in vaccine research and development for over two decades, with high academic status and extensive experience in the industry. Liu's team has been deeply involved in the field of vaccine research and development for many years. Its vaccine portfolio strategically aimed at major disease and the team is actively deploying large-scale production. We admire Liu's great enthusiasm for the vaccine industry and his strong sense of responsibility and commitment. Recbio is now the leading vaccine company in China. After the successful listing, we believe that Recbio will continue to make breakthroughs in its core field of new adjuvant and vaccines to benefit more patients."

Frank Hong, the Managing Director of Legend Capital, said: "After the outbreak of the pandemic, the vaccine industry has stepped into a high-speed development stage after years of accumulation on technology and talent pool. Recbio is one of the few vaccine companies with high-quality technology platforms, which can continuously produce high-quality vaccine products to meet unmet clinical needs. We are optimistic about Recbio's future of its core pipelines, including the HPV vaccine, recombinant shingles vaccine REC610 and COVID-19 vaccine. Advanced with its disruptive technology in the field of recombinant protein vaccines, Recbio is expected to be a company with strong competitiveness in the global market."

Legend Capital has long paid close attention to investments in the field of life sciences. In addition to Recbio, there are other portfolio companies listed on A shares or H shares, including Pharmaron Inc. (300759.SZ; 03759.HK), KingMed Diagnostics (603882.SH), WuXi AppTec(603259.SH; 02359.HK), WuXi Biologics (02269.HK), Innovent Biologics (01801.HK), Berry Genomics (000710.SZ), Harbour BioMed (02142.HK), New Horizon Health (06606.HK), Chemclin Diagnostics (688468.SH), etc.


Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comOn 31 March 2022, Legend Capital's portfolio company Jiangsu Recbio Technology Co., Ltd. ("Recbio", stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange.

Cardano: With soaring on-chain transactions, here’s how far ADA can go

Cardano could push toward $1.62 as on-chain transactions soaredDisclaimer: The findings of the following analysis are the sole opinions of the writer and should not be considered investment advice IntoTheBlock reported that the number of large transactions on the Cardano blockchain had increased by an enormous margin, which indicated that there was increasing institutional demand. Santiment also noted an uptick in the number of […]

Unlocking the true value of crypto assets with YouHodler

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass AdoptionThe rapid growth of cryptocurrency shows no signs of stopping. As traditional assets lose yield, institutional and ordinary investors are shifting to cryptocurrency.  As crypto markets are highly volatile, most investors do not want to sell their holdings even when the markets are down. This opens a huge market for crypto lending platforms like YouHodler […]

Unlocking the true value of crypto assets with YouHodler

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass AdoptionThe rapid growth of cryptocurrency shows no signs of stopping. As traditional assets lose yield, institutional and ordinary investors are shifting to cryptocurrency.  As crypto markets are highly volatile, most investors do not want to sell their holdings even when the markets are down. This opens a huge market for crypto lending platforms like YouHodler […]
Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Unlocking the true value of crypto assets with YouHodler

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass AdoptionThe rapid growth of cryptocurrency shows no signs of stopping. As traditional assets lose yield, institutional and ordinary investors are shifting to cryptocurrency.  As crypto markets are highly volatile, most investors do not want to sell their holdings even when the markets are down. This opens a huge market for crypto lending platforms like YouHodler […]

Bitcoin Game Theory Intensifies: Russia Accepts Bitcoin For Exports

News out of Russia indicates the country is open to accepting Bitcoin and other hard assets in exchange for oil and other commodity exports.

Bitcoin Game Theory Intensifies: Russia Accepts Bitcoin For Exports

News out of Russia indicates the country is open to accepting Bitcoin and other hard assets in exchange for oil and other commodity exports.

Bitcoin Game Theory Intensifies: Russia Accepts Bitcoin For Exports

News out of Russia indicates the country is open to accepting Bitcoin and other hard assets in exchange for oil and other commodity exports.

BTC, ETH, BNB, XRP, ADA, LUNA, SOL, AVAX, DOT, DOGE

This week Bitcoin (BTC) and choose altcoins broke above their quick resistance ranges and moved increased, which propelled the whole crypto market capitalization above $2 trillion on March 24. One of the triggers that could have driven crypto prices higher was BlackRock CEO Larry Fink’s letter to shareholders the place he mentioned that the Russia-Ukraine […]

The post BTC, ETH, BNB, XRP, ADA, LUNA, SOL, AVAX, DOT, DOGE appeared first on Bitcoin Upload.

BTC, ETH, BNB, XRP, ADA, LUNA, SOL, AVAX, DOT, DOGE

This week Bitcoin (BTC) and choose altcoins broke above their quick resistance ranges and moved increased, which propelled the whole crypto market capitalization above $2 trillion on March 24. One of the triggers that could have driven crypto prices higher was BlackRock CEO Larry Fink’s letter to shareholders the place he mentioned that the Russia-Ukraine […]

The post BTC, ETH, BNB, XRP, ADA, LUNA, SOL, AVAX, DOT, DOGE appeared first on Bitcoin Upload.

Tag Template - News Hub PRO CoinGenius Hosts Virtual Crypto Event The Road To Mass Adoption

Recent articles

spot_img